ERBB2 and neoplasm: The HER2 expression of the different tumor cell lines strongly differs (from less than 1,700 to more than 578,000 HER2 receptors/cell) and showed strong cytotoxic effect of the bispecific HER2xCD3 and the trispecific eFab-eIg molecule with dependency of target cell binding.